Bristol-Myers Squibb to buy Inhibitex for $2.5 billion
January 8, 2012 in MedicationsPharmaceutical giant Bristol-Myers Squibb Company announced it was acquiring Inhibitex, Inc., a company specializing in treatment of hepatitis C, for $2.5 billion (1.9 billion euros).
The transaction has been approved by the boards of directors of both companies, the Saturday announcement said.
Inhibitex has been focusing on development of nucleotide medicines designed for treatment of hepatitis C.
Its lead product under development, known as INX-189, has displayed potent antiviral abilities, experts said.
"The acquisition of Inhibitex builds on Bristol-Myers Squibb's long history of discovering, developing and delivering innovative new medicines in virology and enriches our portfolio of investigational medicines for hepatitis C," Lamberto Andreotti, chief executive officer of Bristol-Myers Squibb, said in a statement.
"There is significant unmet medical need in hepatitis C," he added. "This acquisition represents an important investment in the long-term growth of the company."
Russell Plumb, president and CEO of Inhibitex, said the transaction puts INX-189 and his company's other assets in the hands of an organization that can "more optimally develop them."
Bristol-Myers Squibb will finance the acquisition, which is expected to be completed in about a month, from its existing cash resources, officials said.
(c) 2012 AFP
-
Initial Hepatitis C drug trial complete
Sep 02, 2010 |
not rated yet |
0
-
Trials begin on potent new hepatitis C drug
May 14, 2010 |
not rated yet |
0
-
Bristol-Myers recalls Coumadin blood thinner
May 02, 2011 |
not rated yet |
0
-
AIDS drug offered free to the Third World
Feb 15, 2006 |
not rated yet |
0
-
Bristol-Myers Squibb sees 3Q profit dip 2 percent
Oct 26, 2010 |
not rated yet |
0
-
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
May 25, 2012 |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (4) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Potential Breakthrough in Seizure Control
15 hours ago
-
Popping/Cracked sternum.
20 hours ago
-
Which Mental Illness Encompasses This Problem?
20 hours ago
-
A question about drug tolerance
May 23, 2012
-
Poor nutrition leading to overeating?
May 23, 2012
-
Math and dyslexia?
May 21, 2012
- More from Physics Forums - Medical Sciences
More news stories
Missouri opts for untested drug for executions
(AP) -- The same anesthetic that caused the overdose death of pop star Michael Jackson is now the drug of choice for executions in Missouri, causing a stir among critics who question how the state can guarantee ...
Medications
May 24, 2012 |
not rated yet |
4
Aspirin may prevent recurrence of deep vein blood clots
(HealthDay) -- After suffering a type of blood clot called a venous thromboembolism, patients usually take a blood-thinner such as warfarin (Coumadin). But aspirin may do just as well after a period of time, ...
Medications
May 23, 2012 |
not rated yet |
2
|
Patients may receive too much acetaminophen in hospital
(HealthDay) -- Roughly 2.5 percent of admitted hospital patients may receive more than the safe daily cumulative dose of the pain-reliever acetaminophen, best known as Tylenol, on at least one day, according ...
Medications
May 23, 2012 |
1 / 5 (1) |
0
New quality standards limiting elemental impurities in medicines announced
As part of its ongoing efforts to help ensure the quality of medicines, the U.S. Pharmacopeial Convention (USP) has announced two new standards related to elemental impurities: General Chapters Elemental ImpuritiesLimits and ...
Medications
May 23, 2012 |
not rated yet |
0
Quality standards for heparin further strengthened
To help further secure a safe supply of the widelyused blood thinner heparin, a third round of revisions to quality standards for the drug has been advanced by the U.S. Pharmacopeial Convention (USP). USP's Expert Panel ...
Medications
May 23, 2012 |
not rated yet |
0
Keep food safety in mind this memorial day weekend
(HealthDay) -- Picnics, parades and cookouts are as much a part of Memorial Day weekend as tributes to the United States' war veterans.
Travel to high altitudes tied to Crohn's, colitis flare-ups
(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...
Family history of Alzheimer's affects functional connectivity
(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...
Transvaginal mesh op restores pelvic organ prolapse at price
(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...
Weight struggles? Blame new neurons in your hypothalamus
New nerve cells formed in a select part of the brain could hold considerable sway over how much you eat and consequently weigh, new animal research by Johns Hopkins scientists suggests in a study published in the May issue ...